Blog

Refining the First Strike Against EGFR-Mutated Advanced NSCLC – PeerView Institute for Medical Education

PVI/LinkedIn

Nov 18, 2024, 16:59

Refining the First Strike Against EGFR-Mutated Advanced NSCLC – PeerView Institute for Medical Education

PVI (PeerView Institute for Medical Education) shared a post on LinkedIn:

“Join the lung cancer experts Drs. Stephen Liu and Zosia Piotrowska on November 22 at 9:30 AM PST during MaTOS2024 for an EGFR-mutated advanced NSCLC MedEd event.

Learners will gain case-based guidance on interpreting and applying the latest innovations effectively in practice, ensuring they are well-prepared for the frontline management of EGFR-mutated NSCLC.

This activity is supported by an independent educational grant from AstraZeneca.”

Read further.

For more posts like this, visit oncodaily.com.

AstraZeneca cancer EGFR-mutated non-small-cell lung cancer EGFR-mutated NSCLC Lung cancer MaTOS2024 MedEd OncoDaily Oncology Stephen Liu Zosia Piotrowska

China Anti-Cancer Association (CACA) and OncoDaily Announce Strategic Partnership to Advance Global Cancer Care

Donald Trump: Thrilled to announce Robert F. Kennedy Jr. as The United States Secretary of HHS

Overview of ASCO Breakthrough

Robert De Niro and Prostate Cancer: How He Went Against, How He Survived, and More

Isabel Mestres: In a world where the fight against cancer knows no borders, collaboration is not optional - it’s essential

Special Coverage